Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06617494

Endogenous Pain Inhibition Deficiency in Chronic TMD Pain

The Role of Endogenous Pain Inhibition Deficiency in Chronic TMD Pain Pathophysiology

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 74 Years
Healthy volunteers
Accepted

Summary

Temporomandibular disorders (TMDs) involve a range of conditions with varied causes, affecting a large portion of the U.S. population and posing challenges for diagnosis and management, especially in chronic cases. Despite advances in understanding TMD pathophysiology, the role of central sensitization, particularly deficient endogenous pain inhibition, remains unclear. The conditioned pain modulation (CPM) test, used to assess pain inhibition in chronic TMD pain, has produced inconsistent results due to varying testing parameters. The proposed cross-sectional study will investigate the efficiency of endogenous pain inhibition in individuals with chronic TMD pain compared to controls by applying noxious and non-noxious stimuli to facial and non-facial sites. The findings aim to clarify the impact of weaker pain inhibition over the face, how the conditioning stimulus' painfulness affects inhibition and the relationship between pain inhibition and fluctuations in TMD pain intensity.

Conditions

Interventions

TypeNameDescription
OTHERPain modulation testingDuring the visit, noxious heat stimuli will be applied bilaterally to the face and distant body sites as part of conditioned pain modulation (CPM) testing. The test stimuli will be individually tailored to be moderately painful, while the conditioning stimulus will vary in intensity: moderately painful, non-painful, and sham heat. Participants will also record daily TMD pain intensity ratings for seven days before and after the visit.

Timeline

Start date
2024-09-16
Primary completion
2026-09-15
Completion
2026-12-15
First posted
2024-09-27
Last updated
2025-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06617494. Inclusion in this directory is not an endorsement.